Coral Laboratories Limited (BOM:524506)
552.00
-9.90 (-1.76%)
At close: Oct 6, 2026
Coral Laboratories Revenue
Coral Laboratories had revenue of 296.23M INR in the quarter ending June 30, 2026, with 57.39% growth. This brings the company's revenue in the last twelve months to 967.01M, down -5.35% year-over-year. In the fiscal year ending March 31, 2026, Coral Laboratories had annual revenue of 859.00M, down -25.31%. That makes Coral Laboratories the world's 37,332nd largest company by revenue and 3,232nd in India.
Revenue (ttm)
967.01M
Revenue Growth
-5.35%
P/S Ratio
2.04
Revenue / Employee
6.49M
Employees
149
Market Cap
1.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 859.00M | -291.06M | -25.31% |
| Mar 31, 2025 | 1.15B | 313.45M | 37.47% |
| Mar 31, 2024 | 836.60M | 55.42M | 7.09% |
| Mar 31, 2023 | 781.19M | 25.08M | 3.32% |
| Mar 31, 2022 | 756.11M | -209.57M | -21.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Bal Pharma | 3.34B |
| Medico Remedies | 2.38B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 997.10M |